These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

619 related articles for article (PubMed ID: 32430002)

  • 1. Pharmacological management of modifiable cardiovascular risk factors (blood pressure and lipids) following diagnosis of myocardial infarction, stroke and diabetes: comparison between population-based studies in Russia and Norway.
    Cook S; Hopstock LA; Eggen AE; Bates K; Iakunchykova O; Kontsevaya A; McKee M; Schirmer H; Voevoda M; Kudryavtsev AV; Malyutina S; Leon DA
    BMC Cardiovasc Disord; 2020 May; 20(1):234. PubMed ID: 32430002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uncontrolled and apparent treatment resistant hypertension: a cross-sectional study of Russian and Norwegian 40-69 year olds.
    Petersen J; Malyutina S; Ryabikov A; Kontsevaya A; Kudryavtsev AV; Eggen AE; McKee M; Cook S; Hopstock LA; Schirmer H; Leon DA
    BMC Cardiovasc Disord; 2020 Mar; 20(1):135. PubMed ID: 32169049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk Factor Control in Stroke Survivors with Diagnosed and Undiagnosed Diabetes: A Ghanaian Registry Analysis.
    Sarfo FS; Akassi J; Agyei M; Kontoh S; Ovbiagele B
    J Stroke Cerebrovasc Dis; 2020 Dec; 29(12):105304. PubMed ID: 32992189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological treatment of hypertension and hyperlipidemia in Izhevsk, Russia.
    Cybulsky M; Cook S; Kontsevaya AV; Vasiljev M; Leon DA
    BMC Cardiovasc Disord; 2016 Jun; 16():122. PubMed ID: 27255373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adherence to prescription guidelines and achievement of treatment goals among persons with coronary heart disease in Tromsø 7.
    Pedersen E; Garcia BH; Halvorsen KH; Eggen AE; Schirmer H; Waaseth M
    BMC Cardiovasc Disord; 2021 Jan; 21(1):44. PubMed ID: 33478404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Prevalence, Awareness, Treatment, and Control of Cardiovascular Risk Factors in China and the United States.
    Lu Y; Wang P; Zhou T; Lu J; Spatz ES; Nasir K; Jiang L; Krumholz HM
    J Am Heart Assoc; 2018 Jan; 7(3):. PubMed ID: 29374046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends in utilization of lipid- and blood pressure-lowering agents and goal attainment among the U.S. diabetic population, 1999-2008.
    Kuznik A; Mardekian J
    Cardiovasc Diabetol; 2011 Apr; 10():31. PubMed ID: 21496321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of incident myocardial infarction by gender: Interactions with serum lipids, blood pressure and smoking. The Tromsø Study 1979-2012.
    Albrektsen G; Heuch I; Løchen ML; Thelle DS; Wilsgaard T; Njølstad I; Bønaa KH
    Atherosclerosis; 2017 Jun; 261():52-59. PubMed ID: 28448842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood pressure and lipid management fall far short in persons with type 2 diabetes: results from the DIAB-CORE Consortium including six German population-based studies.
    Rückert IM; Schunk M; Holle R; Schipf S; Völzke H; Kluttig A; Greiser KH; Berger K; Müller G; Ellert U; Neuhauser H; Rathmann W; Tamayo T; Moebus S; Andrich S; Meisinger C
    Cardiovasc Diabetol; 2012 May; 11():50. PubMed ID: 22569118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Multifactorial Treatment Targets and Relative Importance of Hemoglobin A1c, Blood Pressure, and Low-Density Lipoprotein-Cholesterol on Cardiovascular Diseases in Chinese Primary Care Patients With Type 2 Diabetes Mellitus: A Population-Based Retrospective Cohort Study.
    Wan EYF; Fung CSC; Yu EYT; Chin WY; Fong DYT; Chan AKC; Lam CLK
    J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28862945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Personal attributes that influence the adequate management of hypertension and dyslipidemia in patients with type 2 diabetes. Results from the DIAB-CORE Cooperation.
    Rückert IM; Maier W; Mielck A; Schipf S; Völzke H; Kluttig A; Greiser KH; Berger K; Müller G; Ellert U; Neuhauser H; Rathmann W; Tamayo T; Moebus S; Andrich S; Meisinger C
    Cardiovasc Diabetol; 2012 Oct; 11():120. PubMed ID: 23035799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic Obstructive Pulmonary Disease (COPD) in Population Studies in Russia and Norway: Comparison of Prevalence, Awareness and Management.
    Cook S; Eggen AE; Hopstock LA; Malyutina S; Shapkina M; Kudryavtsev AV; Melbye H; Quint JK
    Int J Chron Obstruct Pulmon Dis; 2021; 16():1353-1368. PubMed ID: 34025121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicted impact of lipid lowering therapy on cardiovascular and economic outcomes of Swedish atherosclerotic cardiovascular disease guideline.
    Journath G; Hambraeus K; Hagström E; Pettersson B; Löthgren M
    BMC Cardiovasc Disord; 2017 Aug; 17(1):224. PubMed ID: 28814290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suboptimal control of lipid levels: results from the non-interventional Centralized Pan-Russian Survey of the Undertreatment of Hypercholesterolemia II (CEPHEUS II).
    Boytsov S; Logunova N; Khomitskaya Y;
    Cardiovasc Diabetol; 2017 Dec; 16(1):158. PubMed ID: 29246151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single Pill Regimen Leads to Better Adherence and Clinical Outcome in Daily Practice in Patients Suffering from Hypertension and/or Dyslipidemia: Results of a Meta-Analysis.
    Weisser B; Predel HG; Gillessen A; Hacke C; Vor dem Esche J; Rippin G; Noetel A; Randerath O
    High Blood Press Cardiovasc Prev; 2020 Apr; 27(2):157-164. PubMed ID: 32219670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Achievement of multiple therapeutic targets for cardiovascular disease prevention: Retrospective analysis of real practice in Italy.
    Figliuzzi I; Presta V; Citoni B; Miceli F; Simonelli F; Battistoni A; Coluccia R; Ferrucci A; Volpe M; Tocci G
    Clin Cardiol; 2018 Jun; 41(6):788-796. PubMed ID: 29604091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of adiposity on differences in carotid plaque burden in studies conducted in Norway and Russia: a cross-sectional analysis of two populations at very different risk of cardiovascular mortality.
    Imahori Y; Frost C; Mathiesen EB; Ryabikov A; Kudryavtsev AV; Malyutina S; Kornev M; Hughes AD; Hopstock LA; Leon DA
    BMJ Open; 2020 May; 10(5):e036583. PubMed ID: 32381537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular risk factor control is insufficient in young patients with coronary artery disease.
    Christiansen MK; Jensen JM; Brøndberg AK; Bøtker HE; Jensen HK
    Vasc Health Risk Manag; 2016; 12():219-27. PubMed ID: 27307744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of vascular risk factors in the Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST).
    Meschia JF; Voeks JH; Leimgruber PP; Mantese VA; Timaran CH; Chiu D; Demaerschalk BM; Howard VJ; Hughes SE; Longbottom M; Howard AG; Brott TG
    J Am Heart Assoc; 2014 Nov; 3(6):e001180. PubMed ID: 25428209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What factors explain the much higher diabetes prevalence in Russia compared with Norway? Major sex differences in the contribution of adiposity.
    Iakunchykova O; Averina M; Wilsgaard T; Malyutina S; Kudryavtsev AV; Cook S; Wild S; Eggen AE; Hopstock LA; Leon DA
    BMJ Open Diabetes Res Care; 2021 Mar; 9(1):. PubMed ID: 33664061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.